The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: APC vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000038.6(APC):c.531+5G>A

CA010191

127305 (ClinVar)

Gene: APC
Condition: familial adenomatous polyposis 1
Inheritance Mode: Autosomal dominant inheritance
UUID: 692bbce9-fca9-470f-bcdd-32db87381789
Approved on: 2025-05-15
Published on: 2025-05-19

HGVS expressions

NM_000038.6:c.531+5G>A
NM_000038.6(APC):c.531+5G>A
NC_000005.10:g.112775742G>A
CM000667.2:g.112775742G>A
NC_000005.9:g.112111439G>A
CM000667.1:g.112111439G>A
NC_000005.8:g.112139338G>A
NG_008481.4:g.88222G>A
ENST00000502371.3:c.531+5G>A
ENST00000504915.3:c.531+5G>A
ENST00000505084.2:n.587+5G>A
ENST00000505350.2:c.*537+5G>A
ENST00000507379.6:c.561+5G>A
ENST00000509732.6:c.531+5G>A
ENST00000512211.7:c.531+5G>A
ENST00000257430.9:c.531+5G>A
ENST00000257430.8:c.531+5G>A
ENST00000507379.5:c.561+5G>A
ENST00000508376.6:c.531+5G>A
ENST00000508624.5:c.531+5G>A
ENST00000512211.6:c.531+5G>A
NM_000038.5:c.531+5G>A
NM_001127510.2:c.531+5G>A
NM_001127511.2:c.561+5G>A
NM_001354895.1:c.531+5G>A
NM_001354896.1:c.531+5G>A
NM_001354897.1:c.561+5G>A
NM_001354898.1:c.456+5G>A
NM_001354899.1:c.531+5G>A
NM_001354900.1:c.354+5G>A
NM_001354901.1:c.354+5G>A
NM_001354902.1:c.561+5G>A
NM_001354903.1:c.531+5G>A
NM_001354904.1:c.456+5G>A
NM_001354905.1:c.354+5G>A
NM_001354906.1:c.-505+5G>A
NM_001127510.3:c.531+5G>A
NM_001127511.3:c.561+5G>A
NM_001354895.2:c.531+5G>A
NM_001354896.2:c.531+5G>A
NM_001354897.2:c.561+5G>A
NM_001354898.2:c.456+5G>A
NM_001354899.2:c.531+5G>A
NM_001354900.2:c.354+5G>A
NM_001354901.2:c.354+5G>A
NM_001354902.2:c.561+5G>A
NM_001354903.2:c.531+5G>A
NM_001354904.2:c.456+5G>A
NM_001354905.2:c.354+5G>A
NM_001354906.2:c.-505+5G>A
More

Likely Pathogenic

Met criteria codes 4
PP3 PS1_Moderate PS4_Moderate PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for APC Version 2.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
The NM_000038.6(APC):c.531+5G>A variant in APC is an intronic variant which consists of a G>A nucleotide substitution at the +5 position of intron 5 of the APC gene. The results from in silico splicing predictors (SpliceAI and MaxEntScan) indicate that this variant may affect splicing by disrupting the donor splice site of intron 5 of APC (PP3). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant has been reported in 3 probands meeting 2 phenotype points (PS4_Moderate; PMID: 21813337, GeneDX internal cases). The variant has been reported in 3 additional probands with a colorectal cancer/polyposis associated phenotype not meeting phenotypic criteria (PMID: 25980754, 26681312, Ambry internal case). This variant has similar in silico predictions compared to another splicing variant at that same nucleotide position (c.531+5G>C) (PMID: 12010888, 20223039, 19196998, ClinVar ID 279681), which has been classified as likely pathogenic for FAP by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP (PS1_Moderate). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal-dominant inherited FAP based on the ACMG/AMP criteria applied, as specified by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis: criteria PS1_Moderate, PS4_Moderate, PM2_Supporting and PP3 applied (VCEP specifications v2.1.0; date of approval 11/24/2023).
Met criteria codes
PP3
The results from in silico splicing predictors (SpliceAI and MaxEntScan) indicate that this variant may affect splicing by disrupting the donor splice site of intron 5 of APC (PP3).
PS1_Moderate
This variant has similar in silico predictions compared to another splicing variant at that same nucleotide position (c.531+5G>C) (PMID: 12010888, 20223039, 19196998, ClinVar ID 279681), which has been classified as likely pathogenic for FAP by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP (PS1_Moderate).
PS4_Moderate
This variant has been reported in 3 probands meeting 2 phenotype points (PS4_Moderate; PMID: 21813337, GeneDX internal cases). The variant has been reported in 3 additional probands with a colorectal cancer/polyposis associated phenotype not meeting phenotypic criteria (PMID: 25980754, 26681312, Ambry internal case).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.